Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma
- 22 March 2004
- journal article
- case report
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 33 (9), 921-923
- https://doi.org/10.1038/sj.bmt.1704467
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Neutropenia in Patients Treated with RituximabNew England Journal of Medicine, 2003
- Autoimmune thrombocytopenic purpura after autologous stem cell transplantationBone Marrow Transplantation, 2003
- Delayed‐onset neutropenia associated with rituximab therapyBritish Journal of Haematology, 2003
- CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell LymphomaNew England Journal of Medicine, 2002
- Evidence for T-large granular lymphocyte-mediated neutropenia in Rituximab-treated lymphoma patients: report of two casesLeukemia Research, 2001
- Immunotherapy with rituximab during peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.Transplantation and Cellular Therapy, 2000
- Survival Benefit of High-Dose Therapy in Poor-Risk Aggressive Non-Hodgkin’s Lymphoma: Final Analysis of the Prospective LNH87–2 Protocol—A Groupe d’Etude des Lymphomes de l’Adulte StudyJournal of Clinical Oncology, 2000
- Chronic neutropenia mediated by Fas ligandBlood, 2000
- CD8+,CD57+ T cells from healthy elderly subjects suppress neutrophil development in vitro: Implications for the neutropenia of Felty's and large granular lymphocyte syndromesArthritis & Rheumatism, 2000
- Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.Journal of Clinical Oncology, 1998